Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate

BACKGROUND: Rituximab inhibited structural damage at 1 year in patients with rheumatoid arthritis (RA) who had had a previous inadequate response to tumour necrosis factor (TNF) inhibitors. OBJECTIVE: To assess structural damage progression through 2 years. METHODS: Intention-to-treat patients with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cohen, Stanley B, Keystone, Edward, Genovese, Mark C, Emery, Paul, Peterfy, Charles, Tak, Paul Peter, Cravets, Matt, Shaw, Tim, Hagerty, David
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2010
Matèries:
Clinical and Epidemiological Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2935326/
https://ncbi.nlm.nih.gov/pubmed/20439295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2009.119222
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars